Bio-Rad Laboratories Inc. (BIO) is a manufacturer and distributor of its own life science research and clinical diagnostics products. The company has two primary segments: Life Science and Clinical Diagnostics. The company sells its products and services to a diverse client base comprised of scientific research, healthcare, education and government customers.
Let’s take a look at this company and try to explain to investors the reasons this is an apparently appealing investment.
Analyst´s Ratings & Recommendations
The Street Ratings upgraded Bio-Rad from hold to buy. The company’s strengths are: its revenue growth, largely solid financial position with reasonable debt levels, reasonable valuation levels, expanding profit margins and increase in stock price during the past year.
Moreover, due to the repayment of $300 million of subordinated notes, Moody’s Investors Service affirmed the Ba1 Corporate Family Rating and Ba1-PD Probability of Default Rating of the company. Moody’s also affirmed the Ba1 rating on the company’s senior unsecured notes
Top 5 Gas Utility Stocks To Own For 2015: Cardinal Health Inc. (CAH)
Cardinal Health, Inc. operates as a healthcare solutions company that provides health care products and services. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retail customers, hospitals, and alternate care providers in the United States and Puerto Rico. This segment also operates nuclear pharmacies and cyclotron facilities that prepare and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and clinics; offers third-party logistics support services; franchises retail pharmacies under the Medicine Shoppe and Medicap brands; and provides pharmacy and pharmaceutical repackaging services, as well as other services comprising distribution, inventory management, data/reporting, new product launch support, and contract and chargeback administration. The Medical segment distributes a range of medical, surgical, and laboratory products to hospitals, surgery centers, laboratories, physician offices, and other healthcare providers. This segment also develops, manufactures, and sources medical and surgical products, including sterile and non-sterile procedure kits; single-use surgical drapes, gowns, and apparel; exam and surgical gloves; and fluid suction and collection systems. Its medical and surgical products are sold directly or through third-party distributors in the United States, Canada, Europe, South America, and the Asia/Pacific region. The company was founded in 1979 and is headquartered in Dublin, Ohio.
- [By Victor Selva]
The company has a very attractive current ratio of 33.03% which is higher than its comps: Becton Dickinson & Co (BDX), Cardinal Health Inc (CAH), Cooper Companies (COO) and Luxottica Group S.p.A. (LUX).
- [By Dividends4Life]
Linked here is a detailed quantitative analysis of Cardinal Health, Inc. (CAH). Below are some highlights from the above linked analysis:
Company Description: Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers.
Top 5 Gas Utility Stocks To Own For 2015: Mesabi Trust (MSB)
Mesabi Trust operates as a royalty trust in the United States. The company produces iron ore pellets. It holds interest in the Peter Mitchell mine located in the Mesabi Iron Range near Babbitt, Minnesota. The company holds various agreements with the Northshore Mining Company that mines iron ore, which is in the form of taconite, crushes it, separates the iron particles from the non-metallic, and forms the resulting concentrate into pellets that are shipped for use in steel-producing blast furnaces of customers of CCI, a mining company that produces iron pellets in North America. Mesabi Trust was founded in 1919 and is based in New York, New York.
- [By Selena Maranjian]
For starters, imagine that you invested in Mesabi Trust (NYSE: MSB ) about a year ago and you’re down some 20% on your investment. Your holding might be looking to you like an answer to the question, “What is investment panic, Alex?” But don’t be so hasty. Ask yourself why you bought it. Mesabi Trust is a royalty trust that receives and then pays out to shareholders a portion of the proceeds from iron mined by a Cliffs Natural Resources subsidiary. Some might avoid it because royalty trusts often have expiration dates, but it’s worth noting that Mesabi’s is rather far away. But slowdown in demand for ore is a concern, one that has been an issue for Cliffs, too.
Top 5 Gas Utility Stocks To Own For 2015: Nissan Motor Co Ltd (NSANF)
NISSAN MOTOR CO., LTD. is an automobile manufacturer. The Company has two business segments. The Automobile segment is engaged in the manufacturing, trading and distribution of various types of automobiles, marine products and accessories, as well as the research, development and sale of lithium-ion secondary batteries. The Sales Financing segment is engaged in the provision of sales financing, as well as property and casualty insurance services, among others. On November 11, 2013, the Company announced that it had established an Indonesia-based subsidiary, which is engaged in the captive finance business to make loans to the customers of Indonesia. Advisors’ Opinion:
- [By Chris Isidore]
Nissan (NSANF) said it is not aware of any deaths caused by the problem, but can not give details about resulting injuries.
The problem is with the sensors in the front passenger seats that are supposed to tell if an adult or a child is sitting on the seat. Because the risk of injury or death to child is greater from an airbag than from an accident itself, if the system senses there is not enough weight in the front passenger seats, that airbag will not deploy.
- [By Chris Isidore]
Japan’s weak yen policy has been a tremendous boon for Japanese rivals such as Toyota Motor (TM), Honda (HMC) and Nissan (NSANF), since the dollars they get for U.S. sales translate into more yen.
- [By Peter Valdes-Dapena]
Six of the cars earned the Institute’s lowest rating of “Poor.” Those were the Nissan (NSANF) Versa, Toyota (TM) Prius c, Hyundai Accent, the Mitsubishi Mirage, Chrysler Group’s Fiat 500 and the Honda (HMC) Fit. The Mazda2, Kia Rio, Toyota Yaris and Ford (F, Fortune 500) Fiesta were deemed Marginal, the second-worst of four possible ratings. Most of these cars have done well in the Institute’s other crash tests and in government tests. The Insurance Institute is a private organization financed by auto insurers.
- [By Blake Ellis]
Industries boasting the highest percentage of companies with perfect scores include law, banking and financial services, and retail and consumer products. Companies new to the 100% club include Nissan (NSANF), General Electric (GE, Fortune 500) and Procter & Gamble (PG, Fortune 500). Other companies among the most improved this year (though they haven’t achieved perfect scores yet) include Wal-Mart (WMT, Fortune 500), which saw its score jump from a 60 to 80 after it introduced same-sex benefits for employees, and Cracker Barrel (CBRL), which rose 10 points to a score of 45 after it launched a LGBT employee network and implemented a non-discrimination policy for LGBT employees.
Top 5 Gas Utility Stocks To Own For 2015: China Gerui Advanced Materials Group Limited(CHOP)
China Gerui Advanced Materials Group Limited engages in the manufacture and sale of cold-rolled narrow strip steel products in the People’s Republic of China. The company converts steel manufactured by third parties into thin steel sheets and strips. It sells its products directly to its customers in a range of industries, including food and industrial packaging, construction and household decorations materials, electrical appliances, and telecommunications wires and cables industries. The company was formerly known as Golden Green Enterprises Limited and changed its name to China Gerui Advanced Materials Group Limited in December 2009. China Gerui Advanced Materials Group Limited is based in Zhengzhou, China.
- [By Jake L’Ecuyer]
Leading and Lagging Sectors
On Tuesday, the basic materials sector proved to be a source of strength for the US market after Yellen statement. Huntsman (NYSE: HUN) shares surged 2.62 percent after reporting strong quarterly earnings, while China Gerui Advanced Materials Group (NASDAQ: CHOP) gained around 2.5 percent.
Top 5 Gas Utility Stocks To Own For 2015: Central Europe Russia and Turkey Fund Inc (CEE)
Central Europe and Russia Fund, Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund seeks long-term capital appreciation primarily through investment in equity and equity-linked securities of issuers domiciled in Central Europe and Russia. The Fund’s portfolio includes investments in Russian, Polish, Hungarian, Czech Republic, Turkish, Austrian, Dutch, Cyprus, Bermuda and Virgin Islands common stocks.
The Fund invests in various industries, including commercial banks, diversified telecommunication services, food products, metals and mining, personal products, wireless telecommunication services, building products, construction and engineering, diversified telecommunication services, media, pharmaceuticals, automobiles, and oil, gas and consumable fuels. The Fund is managed and advised by subsidiaries of the Deutsche Bank Group. The Fund’s investment advisor is Deutsche Asset Management International GmbH. The Fund’s manager is Deutsche Investment Management Americas Inc.
- [By Jake L’Ecuyer]
Among the financial stocks, Ashford Hospitality Trust (NYSE: AHT) was down more than 5.7 percent, while The Central Europe, Russia and Turkey Fund (NYSE: CEE) tumbled around 5 percent.
- [By STANSBERRYRESEARCH]
With emerging market speculation heating up again, TRF is trading for a 24% premium right now. If that premium climbs any higher, we predict another obliteration. – Brian Hunt, DailyWealth, December 21, 2006
We published that note in December 2006. By March 2009, it had lost more than 90% of its value. Perhaps more importantly to any long-term, buy-and-hold investor, the decline we foresaw in the fund would have wiped out more than 100% of the accumulated capital gains, assuming you invested as much as 15 years earlier. Now… I'd like you to look at the chart one more time. Look at what happened to the fund in the first half of 2009. It went nearly straight up. On April 17, 2009, we told subscribers to buy Russian stocks. Instead of using TRF, Steve Sjuggerud recommended a nearly identical Scudder Fund, the Central Europe and Russia Fund (NYSE: CEE). Both went up 150% from their March lows. So if you followed the buy-and-hold strategy in Russian stocks over the last 15 years, you would have made a very small amount of money – or lost money, depending on when you sold your shares. On the other hand, if you applied a few of our secrets, you could have easily traded this fund for more than 100% gains in only a few weeks. And if you watch this fund, you'll be able to make trades like this three or four times each decade. If you watch other similar funds, you'll be able to make trades like this once or twice a year. And let me tell you one more thing about this situation. In January 2007, when TRF was widely overvalued and when most individual investors were clamoring to buy shares – despite the premium valuation – we checked to see if we could sell the fund short. We knew it was going to collapse and wanted to profit directly as it fell. But we couldn't. Why not? Because other professionals had already borrowed all of the available shares to sh